[Press Release] Vaccine success raises hopes for the end of the pandemic

2019 Member (8)

Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study.

A vaccine developed by Pfizer Inc. and BioNTech SE protects most people from Covid-19, according to a study whose early findings sent stock prices surging and were hailed by the top U.S. infectious-disease specialist as “extraordinary.”

The shot prevented more than 90% of symptomatic infections in the trial of tens of thousands of volunteers, the most encouraging scientific advance so far in the battle against the coronavirus. While the results are preliminary, they may pave the way for the companies to seek an emergency-use authorization if further research shows the vaccine is also safe.

Pfizer shares rose as much as 15% and were trading 8.8% higher at 3:14 p.m. in New York, while BioNTech American depositary receipts surged as much as 24%. The news fueled a global rally that added more than $1.8 trillion to the value of the MSCI All Country World Index.

To more please click the link below:

https://www.bloomberg.com/news/articles/2020-11-09/pfizer-s-covid-vaccine-prevents-90-of-infections-in-large-study?srnd=premium-asia&fbclid=IwAR1GwQ8Ymz2BM-gF8qwB-aSaHOppYlP9Iru-_X1zIZhA0Lrq7MOQKnWM8vk

UPCOMING EVENTS
[Webinar Series] with Medical Doctors of International SOS
January 27 @ 3:00 pm - 4:00 pm

[Webinar Series] National Emergency Management Agency
January 21 @ 11:00 am - 12:00 pm

RECENT NEWS
‘Mozzies Got Talent’
January 13, 2021

[Member Update] Oyu Tolgoi LLC and Tax Payment
January 13, 2021

AustCham Mongolia’s Newsletter Q4 – 2020
December 25, 2020

Merry Christmas!
December 25, 2020

What is the effect on the body after covid 19?
December 21, 2020